[go: up one dir, main page]

AU2001264900A1 - Pharmaceutical use of fibulin-1 - Google Patents

Pharmaceutical use of fibulin-1

Info

Publication number
AU2001264900A1
AU2001264900A1 AU2001264900A AU6490001A AU2001264900A1 AU 2001264900 A1 AU2001264900 A1 AU 2001264900A1 AU 2001264900 A AU2001264900 A AU 2001264900A AU 6490001 A AU6490001 A AU 6490001A AU 2001264900 A1 AU2001264900 A1 AU 2001264900A1
Authority
AU
Australia
Prior art keywords
fibulin
pharmaceutical use
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001264900A
Inventor
Kristof Chwalisz
Bernard Haendler
Holger Hess-Stump
Bruce Lessey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
University of North Carolina at Chapel Hill
Original Assignee
Schering AG
University of North Carolina at Chapel Hill
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG, University of North Carolina at Chapel Hill filed Critical Schering AG
Publication of AU2001264900A1 publication Critical patent/AU2001264900A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2001264900A 2000-05-24 2001-05-24 Pharmaceutical use of fibulin-1 Abandoned AU2001264900A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US57749900A 2000-05-24 2000-05-24
US09/577,499 2000-05-24
PCT/US2001/016791 WO2001089548A2 (en) 2000-05-24 2001-05-24 Pharmaceutical use of fibulin-1

Publications (1)

Publication Number Publication Date
AU2001264900A1 true AU2001264900A1 (en) 2001-12-03

Family

ID=24308988

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001264900A Abandoned AU2001264900A1 (en) 2000-05-24 2001-05-24 Pharmaceutical use of fibulin-1

Country Status (4)

Country Link
EP (1) EP1301195A2 (en)
JP (1) JP2004504275A (en)
AU (1) AU2001264900A1 (en)
WO (1) WO2001089548A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011500856A (en) * 2007-10-31 2011-01-06 シーアールシー フォー アズマ アンド エアウェイズ エルティーディー Methods and compositions for modulating airway tissue remodeling
WO2010010201A1 (en) 2008-07-22 2010-01-28 Equipo Ivi Investigacion Sl Gene expression profile as a marker of endometrial receptivity
SMT202400270T1 (en) 2014-06-17 2024-07-09 Asherman Therapy S L Stem cell therapy in endometrial pathologies
CN113621699A (en) * 2021-08-10 2021-11-09 张存泰 Fibulin-1 protein as vascular aging molecular marker and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6299390A (en) * 1989-08-18 1991-04-03 American National Red Cross, The Fibulin
WO1997038014A1 (en) * 1996-04-04 1997-10-16 Amgen Inc. Fibulin pharmaceutical compositions and related methods

Also Published As

Publication number Publication date
JP2004504275A (en) 2004-02-12
WO2001089548A2 (en) 2001-11-29
WO2001089548A3 (en) 2003-01-23
EP1301195A2 (en) 2003-04-16

Similar Documents

Publication Publication Date Title
AU2001235691A1 (en) Use of paullone derivatives for making medicines
AU2001277741A1 (en) 2-aminopyridine compounds and use thereof as drugs
AU2002239370A1 (en) Signal tampon
AU2001280188A1 (en) Pyrazolopyridine compound and pharmaceutical use thereof
AU2001269508A1 (en) Drugs or cosmetics
AU2002257582A1 (en) Pharmaceutical formulation
AU2001275007A1 (en) Methods of testing materials
AU2002232468A1 (en) Pharmaceutical heterocyclic compounds
AU2002221099A1 (en) Combination drugs
AU2001227084A1 (en) N-arylhydrazide compounds and use thereof as drugs
AU2002230781A1 (en) Pharmaceutical uses and synthesis of benzobicyclooctanes
AU4085201A (en) Pharmaceutical composition
AU2001264900A1 (en) Pharmaceutical use of fibulin-1
AU2001251004A1 (en) Detection of viable agents
AU2001268236A1 (en) Use of aicar and related compounds
AU4432001A (en) Trityl-type compounds and their use
AU2001292578A1 (en) Pharmaceutical compounds
AU3586401A (en) Pharmaceutical composition
AUPR548601A0 (en) Pyrazolopyrazinecompound and pharmaceutical use thereof
AU2001272490A1 (en) Use of galiella lactone
AU2001278705A1 (en) Pharmaceutical composition
AU2001228784A1 (en) Inositol derivatives and their pharmaceutical use
AU2001259564A1 (en) Pharmaceutical compositions and methods for use
AU2001276556A1 (en) Novel pharmaceutical use of quinnoline derivatives
AU2002215923A1 (en) Use of medicaments